Related Experiment Video
Updated: May 1, 2026
09:25
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
10.8K
CDC Grand Rounds: global tobacco control.
MMWR. Morbidity and Mortality Weekly Report
|April 5, 2014
Summary
Tobacco use is the leading cause of preventable death globally, causing millions of deaths annually. If current trends continue, 500 million people alive today will die from tobacco products.
Area of Science:
- Public Health
- Epidemiology
- Global Health
Background:
- Tobacco use is the leading global cause of preventable death.
- Tobacco use caused 100 million deaths in the 20th century and 6 million in 2011.
- Tobacco use causes more deaths annually than HIV/AIDS, tuberculosis, and malaria combined.
Purpose of the Study:
- To analyze the global impact and trends of tobacco use.
- To highlight the mortality associated with lifetime tobacco product consumption.
- To project future mortality trends if current tobacco use patterns persist.
Main Methods:
- Analysis of global tobacco consumption data from 1880 to 2009.
- Examination of mortality statistics linked to tobacco use.
- Projection of future deaths based on current trends in tobacco consumption.
Main Results:
- Manufactured cigarettes constitute 96% of global tobacco sales.
- Global cigarette consumption increased from 10 billion to 5.9 trillion annually between 1880 and 2009.
- Men smoke at significantly higher rates than women globally, with disparities in certain countries.
Conclusions:
- Tobacco use is a critical global health crisis with devastating mortality.
- Current trends indicate a dire future, with 500 million people alive today at risk of dying from tobacco.
- All tobacco-related deaths are preventable, underscoring the need for urgent public health interventions.
More Related Videos
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:26Principles of Disease Surveillance
853
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
853
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33